Top

Published in:

01-12-2018 | Original Article

A randomized controlled trial comparing helium-neon laser therapy and infrared laser therapy in patients with diabetic foot ulcer

Authors: Sayed A. Tantawy, Walid K. Abdelbasset, Dalia M. Kamel, Saud M. Alrawaili

Published in: Lasers in Medical Science | Issue 9/2018

Abstract

This study aimed to compare the effects of (HNLT) and (ILT) on diabetic foot ulcer. Sixty-five patients with diabetic foot ulcer (51 males and 14 females) aged 50–60 years. The participants were classified randomly to two groups, groups I and II. Group I received helium-neon laser therapy (HNLT) and conventional therapy with and group II received infrared laser therapy (ILT) and conventional therapy with for 8 weeks. Ulcer surface area was assessed using a sheet of cellophane paper at the beginning of the study, after 4 weeks, and after 8 weeks at the end of the study. At the beginning of the study, baseline clinical characteristics showed non-significant differences between the two groups (p > 0.05). After 4 weeks intervention, there were significant improvements in ulcer surface area in the two groups (p < 0.05). At the end of the study, after 8 weeks intervention, there were higher reduction in ulcer area in HNLT group more than ILT group, but this difference was statistically non- significant between the two groups (p > 0.05). The present study demonstrates that HNLT and ILT have similar effects to control diabetic foot ulcer in a short-term (up to 8 weeks). Eight weeks of laser therapy have beneficial impacts in diabetic foot ulcer.

Kajagar B, Godhi A, Pandit A et al (2012) Efficacy of low level laser therapy on wound healing in patients with chronic diabetic foot ulcers—a randomized control trial. Indian J Sur 74(5):359–363CrossRef

Volmer-Thole M, Lobmann R (2016) Neuropathy and diabetic foot syndrome. Int J Mol Sci17 (6):917CrossRef

Boulton AJ (2014) Diabetic neuropathy and foot complications. Handb Clin Neurol 126:97–107CrossRef

Lobmann R (2011) Diabetic foot syndrome. Internist 52:539–548CrossRef

Monteiro-Soares M, Boyko E, Ribeiro J et al (2011) Risk stratification systems for diabetic foot ulcers: a systematic review. Diabetologia 54(6):1585–1585CrossRef

Bakker K, Foster AVM and van Houtoum, WH (2005) Time to act. The Netherlands: International Diabetes Federation and International Working Group of the Diabetic Foot

Papanas N, Maltezos E, Edmonds M (2006) The diabetic foot: a plea for the elementary? Acta Diabetol 43(4):152–153CrossRef

Pataky Z, Assal J, Conne P et al (2005) Plantar pressure distribution in type 2 diabetic patients without peripheral neuropathy and peripheral vascular disease. Diabet Med 22(6):762–767CrossRef

Armstrong D, Peters E, Athanasiou K et al (1998) Is there a critical level of plantar foot pressure to identify patients at risk for neuropathic foot ulceration? J Foot Ankle Surg 37(4):303–307CrossRef

10.

Boulton AJ, Hardisty CA, Betts RP et al (1983) Dynamic foot pressure and other studies as diagnostic and management aids in diabetic neuropathy. Diabetes Care 6:26–33CrossRef

11.

Duckworth T, Boulton AJ, Betts RP et al (1985) Plantar pressure measurements and the prevention of ulceration in the diabetic foot. J Bone Joint Surg (Br) 67:79–85CrossRef

12.

Lavery LA, Armstrong DG, Wunderlich RP et al (2003) Predictive value of foot pressure assessment as part of a population based diabetes disease management program. Diabetes Care 26:1069–1073CrossRef

13.

Veves A, Murray HJ, Young MJ et al (1992) The risk of foot ulceration in diabetic patients with high foot pressure: a prospective study. Diabetologia 35:660–663CrossRef

14.

Frykberg RG, Lavery LA, Pham H et al (1998) Role of neuropathy and high foot pressures in diabetic foot ulceration. Diabetes Care 21:1714–1719CrossRef

15.

Ctercteko GC, Dhanendran M, Hutton WC et al (1981) Vertical forces acting on the feet of diabetic patients with neuropathic ulceration. Br J Surg 68:608–614CrossRef

16.

Shaw JE, van Schie CH, Carrington AL et al (1998) An analysis of dynamic forces transmitted through the foot in diabetic neuropathy. Diabetes Care 21:1955–1959CrossRef

17.

Mayfield JA, Reiber GE, Sanders LJ et al (1998) Preventive foot care in people with diabetes. Diabetes Care 21:2161–2177CrossRef

18.

Boulton AJ, Franks CI, Betts RP et al (1984) Reduction of abnormal foot pressures in diabetic neuropathy using a new polymer insole material. Diabetes Care 7:42–46CrossRef

19.

Cade W (2008) Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys Ther 88(11):1322–1335CrossRef

20.

Zakaria H, Adel S, Tantawy S (2008) The role of physical therapy intervention in the management of diabetic neuropathic foot ulcers. Bull Fac Ph Th Cairo Univ 13(2):63–72

21.

Tchanque-Fossuo CN, Ho D, Dahle SE et al (2016) A systematic review of low-level light therapy for treatment of diabetic foot ulcer. Wound Repair Regen 24(2):418–426CrossRef

22.

Gebala-Prajsnar K, Stanek A, Pasek J et al (2016) Selected physical medicine interventions in the treatment of diabetic foot syndrome. Acta Angiologica 21(4):140–145CrossRef

23.

Maiya GA, Kumar P, Rao L (2005) Effect of low intensity heliumneon (He-Ne) laser irradiation on diabetic wound healing dynamics. J Photomed Laser Surg 23(2):187–190CrossRef

24.

Walker MD, Rumpf S, Baxter GD et al (2000) Effect of low-intensity laser irradiation (660nm) on a radiation- impaired wound -healing model in murine skin. J Laser Surg Med 26(1):41–47CrossRef

25.

Mokmeli S, Daemi M, SHIRAZI Z et al (2010) Evaluating the efficiency of low level laser therapy (LLLT) in combination with intravenous laser therapy (IVL) on diabetic foot ulcer, added to conventional therapy. Lasers Med Sci 1(1):8–13

26.

Ebrahimi T, Moslemi N, Rokn A et al (2012) The influence of low-intensity laser therapy on bone healing. J Dent 9(4):238–248

27.

Beckmann K, Meyer-Hamme G, Schröder S (2014) Low level laser therapy for the treatment of diabetic foot ulcers: a critical survey. Evid Based Complement Alternat Med 4:1–9CrossRef

28.

Kaviani A, Djavid G, Ataie-Fashtami L et al (2011) A randomized clinical trial on the effect of low-level laser therapy on chronic diabetic foot wound healing: a preliminary report. Photomed Laser Surg 29(2):109–114CrossRef

29.

Majeske C (1992) Reliability of wound surface area measurements. Phys Ther 72(2):138–141CrossRef

30.

Kilík R, Lakyová L, Sabo J et al (2014) Effect of equal daily doses achieved by different power densities of low-level laser therapy at 635 nm on open skin wound healing in normal and diabetic rats. Biomed Res Int 2014:269253. https://doi.org/10.1155/2014/269253 CrossRefPubMedPubMedCentral

31.

de Sousa NT, Gomes RC, Santos MF et al (2016) Red and infrared laser therapy inhibits in vitro growth of major bacterial species that commonly colonize skin ulcers. Lasers Med Sci 31(3):549–556CrossRef

32.

Tafur J, Mills PJ (2008) Low-intensity light therapy: exploring the role of redox mechanisms. Photomed Laser Surg 26(4):323–328CrossRef

33.

Enoch S, Grey JE, Harding KG (2006) ABC of wound healing. Recent advances and emerging treatments. BMJ 332:962–965CrossRef

34.

Houreld NN (2014) Shedding light on a new treatment for diabetic wound healing: a review on phototherapy. Sci World J 2014:1–13CrossRef

35.

Maiya AG, Kumar P, Nayak S (2009) Photo- stimulatory effect of low energy helium-neon laser irradiation on excisional diabetic wound healing dynamics in wistar rats. Indian J Dermatol 54:323–329CrossRef

36.

Sousa RG, Batista KN (2016) Laser therapy in wound healing associated with diabetes mwllitus—review. An Bras Dermatol 91(4):489–493CrossRef

37.

De Araujo CE, Ribeiro MS, Favaro R et al (2007) Ultrastructural and autoradiographical analysis show a faster skin repair in He-Ne laser-treated wounds. J Photochem Photobiol B 86(2):87–96CrossRef

38.

Kahn F, Sookram C, Saraga F (2015) Utilization of laser therapy in dermal ulceration secondary to diabetes mellitus: a case profile. Diabetic Foot Canada 3(1):26–30

39.

Medrado AR, Pugliese LS, Ries SR et al (2003) Influence of low level laser therapy on wound healing and its biological action upon myofibroplasts. Lasers Surg Med 32(3):239–244CrossRef

40.

Chaves ME, Arouja AR, Piancastelli AC et al (2014) Effects of low-power light therapy on wound healing: LASER × LED. An Bras Dermatol 89(4):616–623CrossRef

41.

Tubachi P, Godhi A (2015) Antibacterial effect of low level laser therapy in infective diabetic foot ulcers. IOSR J Dent Med Sci 14(9):110–114

Title: A randomized controlled trial comparing helium-neon laser therapy and infrared laser therapy in patients with diabetic foot ulcer
Authors: Sayed A. Tantawy
Walid K. Abdelbasset
Dalia M. Kamel
Saud M. Alrawaili
Publication date: 01-12-2018
Publisher: Springer London
Published in: Lasers in Medical Science / Issue 9/2018
Print ISSN: 0268-8921
Electronic ISSN: 1435-604X
DOI: https://doi.org/10.1007/s10103-018-2553-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

A randomized controlled trial comparing helium-neon laser therapy and infrared laser therapy in patients with diabetic foot ulcer

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 9/2018

Interleukin-10 and collagen type II immunoexpression are modulated by photobiomodulation associated to aerobic and aquatic exercises in an experimental model of osteoarthritis

Evaluation of the effects of Er:YAG laser, Nd:YAG laser, and two different desensitizers on dentin permeability: in vitro study

Gold nanorod-assisted near-infrared stimulation of bullfrog sciatic nerve

Low-level laser therapy combined to functional exercise on treatment of fibromyalgia: a double-blind randomized clinical trial

Glomuvenous malformations: dual PDL-Nd:YAG laser approach

Diurnal variations and pulpal status: is there a need for FFT besides LDF?